Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Bloodgood_Brianna_1000x714_ENV

Brianna M. Bloodgood

Associate

New York +1 212 841 1099

  • About
  • Representative Matters
  • Credentials
  • About

    Brianna Bloodgood counsels clients on a broad range of corporate transactional and advisory matters with particular experience in the life sciences and financial services industries.

    Brianna regularly represents clients in a variety of transactions, including initial public offerings and other primary and secondary registered offerings, private placements, exchange offers, transactions involving special purpose acquisition companies (SPACs), mergers and acquisitions and similar matters. She also advises public company clients across industries in the preparation of SEC periodic reports, proxy statements and beneficial ownership reports, and on other securities law and stock exchange compliance matters. Brianna also counsels public companies on a variety of corporate governance matters, including board and committee composition and procedures, environmental social and governance (ESG) programs, internal and disclosure controls, insider trading and similar matters.

    Brianna’s recent pro bono work includes representing charitable organizations in connection with corporate and tax matters, as well as victims of domestic violence in immigration proceedings.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters
    • NewAmsterdam Pharma in its $450 million going public deSPAC merger with Frazier Lifesciences Acquisition Corporation.
    • Entasis Therapeutics in $113 million tender offer and sale to Innoviva.
    • BioNTech SE in its $150 million Nasdaq IPO.
    • Uber Technologies, Inc. in connection with its IPO on the New York Stock Exchange and its subsequent issuance of $500 million of senior unsecured notes.
    • Five Star Bancorp in its $100 million Nasdaq IPO.
    • WSFS Financial Corporation in its $1.5 billion acquisition of Beneficial Bancorp, Inc. and $976 million acquisition of Bryn Mawr Trust Corporation.
    • Republic Services in $2 billion of senior notes offerings.
    • Veritex Holdings, Inc. in a private placement of $75 million fixed-to-floating rate notes and subsequent A/B exchange offer.
    • Valley National Bancorp in its acquisition of the Westchester Bank Holding Corporation.
    • The underwriters in IBERIABANK Corporation’s $100 million public offering of depositary shares.
    • The underwriters in a follow-on public offering of ADSs of a clinical-stage biopharmaceutical company focused on the development of novel immunotherapy products for cancer patients.
    • Boston Children’s Hospital in its $51.5 million monetization of a portion of its royalties relating to Vonvendi.

    Areas of Expertise

  • Credentials
    Education
    • University of Pennsylvania Law School, J.D., 2017
        • magna cum laude
        • Order of the Coif
        • University of Pennsylvania Law Review, Senior Editor
    • University of Pennsylvania Perelman School of Medicine, M.B.E., 2017
    • Boston University, B.A., 2014
        • summa cum laude
    Bar Admissions
    • New York
    Pro Bono
    • Counsels charitable organizations in connection with corporate formation and federal tax-exempt status applications.
    • Represents victims of domestic violence seeking U-Nonimmigrant Status from U.S. Citizenship and Immigration Services (USCIS).
    Memberships and Affiliations
    • Producer for the ABA Business Law section’s M&A webinars.

    Areas of Expertise

News and Insights

Events